
### [DOID:9455](http://purl.obolibrary.org/obo/DOID_9455)
**Label:** lipid storage disease

**Subclasses:** [DOID:14503](http://purl.obolibrary.org/obo/DOID_14503) (neuronal ceroid lipofuscinosis), [DOID:1926](http://purl.obolibrary.org/obo/DOID_1926) (Gaucher's disease), 

**Corr. equiv. classes:** [Orphanet:355](http://www.orpha.net/ORDO/Orphanet_355), [Orphanet:79262](http://www.orpha.net/ORDO/Orphanet_79262), [OMIM:PS256730](http://purl.obolibrary.org/obo/OMIM_PS256730), [Orphanet:216](http://www.orpha.net/ORDO/Orphanet_216), 

**Class expressions from DL-Learner:**

- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:3000036](http://purl.obolibrary.org/obo/HP_3000036) (Abnormality of head blood vessel) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0031477](http://purl.obolibrary.org/obo/HP_0031477) (Abnormal mitral valve morphology) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0012614](http://purl.obolibrary.org/obo/HP_0012614) (Abnormal urine cytology) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0012211](http://purl.obolibrary.org/obo/HP_0012211) (Abnormal renal physiology) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0012145](http://purl.obolibrary.org/obo/HP_0012145) (Abnormality of multiple cell lineages in the bone marrow) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0012115](http://purl.obolibrary.org/obo/HP_0012115) (Hepatitis) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0011915](http://purl.obolibrary.org/obo/HP_0011915) (Cardiovascular calcification) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 62.50%
- [HP:0001522](http://purl.obolibrary.org/obo/HP_0001522) (Death in infancy) and [HP:0011849](http://purl.obolibrary.org/obo/HP_0011849) (Abnormal bone ossification) 62.50%


